IRIDEX CORP Proceeds from Sale of Intangible Assets
IRIDEX CORP (IRIX) reported Proceeds from Sale of Intangible Assets of $175.00 thousand for the 12-month period ending 2017-12-30, per its 10-K filed 2019-03-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfIntangibleAssets · last filed 2019-03-29
- IRIDEX CORP proceeds from sale of intangible assets for the quarter ending 2017-12-30 was $0.00.
- IRIDEX CORP proceeds from sale of intangible assets for fiscal 2017 was $175.00K.
| Period end | Proceeds from Sale of Intangible Assets 1 month | Proceeds from Sale of Intangible Assets 3 month | Proceeds from Sale of Intangible Assets 9 month | Proceeds from Sale of Intangible Assets 12 month |
|---|---|---|---|---|
| 2017-12-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $175.00K 10-K · filed 2019-03-29 | ||
| 2017-09-30 | $175.00K 10-Q · filed 2018-11-06 | |||
| 2017-08-31 | $175.00K 10-Q · filed 2017-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |